US12179203B2 - Method for reagent-specific driving EWoD arrays in microfluidic systems - Google Patents
Method for reagent-specific driving EWoD arrays in microfluidic systems Download PDFInfo
- Publication number
- US12179203B2 US12179203B2 US17/497,512 US202117497512A US12179203B2 US 12179203 B2 US12179203 B2 US 12179203B2 US 202117497512 A US202117497512 A US 202117497512A US 12179203 B2 US12179203 B2 US 12179203B2
- Authority
- US
- United States
- Prior art keywords
- droplets
- droplet
- drive
- composition
- droplet operations
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active, expires
Links
- 238000000034 method Methods 0.000 title claims description 50
- 239000003153 chemical reaction reagent Substances 0.000 title description 89
- 238000003491 array Methods 0.000 title description 3
- 239000000203 mixture Substances 0.000 claims abstract description 100
- 238000012545 processing Methods 0.000 claims abstract description 47
- 239000013626 chemical specie Substances 0.000 claims abstract description 26
- 239000012530 fluid Substances 0.000 claims abstract description 20
- 238000002156 mixing Methods 0.000 claims description 32
- 239000011159 matrix material Substances 0.000 claims description 21
- 238000001208 nuclear magnetic resonance pulse sequence Methods 0.000 claims description 16
- 238000011068 loading method Methods 0.000 claims description 12
- 238000003860 storage Methods 0.000 claims description 11
- 230000002596 correlated effect Effects 0.000 claims description 4
- 238000002835 absorbance Methods 0.000 claims description 3
- 238000001816 cooling Methods 0.000 claims description 3
- 238000007865 diluting Methods 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- 239000000376 reactant Substances 0.000 claims description 2
- 210000003739 neck Anatomy 0.000 description 19
- 229920000136 polysorbate Polymers 0.000 description 17
- 239000000243 solution Substances 0.000 description 17
- 239000000047 product Substances 0.000 description 16
- 239000007788 liquid Substances 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- 230000008859 change Effects 0.000 description 8
- 239000011324 bead Substances 0.000 description 7
- 230000015556 catabolic process Effects 0.000 description 7
- 210000004027 cell Anatomy 0.000 description 7
- 238000006731 degradation reaction Methods 0.000 description 7
- 102000039446 nucleic acids Human genes 0.000 description 7
- 108020004707 nucleic acids Proteins 0.000 description 7
- 150000007523 nucleic acids Chemical class 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- 238000013459 approach Methods 0.000 description 6
- 230000001276 controlling effect Effects 0.000 description 6
- 230000000875 corresponding effect Effects 0.000 description 6
- 230000002209 hydrophobic effect Effects 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 239000004094 surface-active agent Substances 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 238000003556 assay Methods 0.000 description 5
- 238000010586 diagram Methods 0.000 description 5
- 230000001965 increasing effect Effects 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 238000012986 modification Methods 0.000 description 5
- 230000004048 modification Effects 0.000 description 5
- 125000003729 nucleotide group Chemical group 0.000 description 5
- 108020004414 DNA Proteins 0.000 description 4
- 102000053602 DNA Human genes 0.000 description 4
- 108091034117 Oligonucleotide Proteins 0.000 description 4
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 4
- 238000004891 communication Methods 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 229920002477 rna polymer Polymers 0.000 description 4
- 238000012935 Averaging Methods 0.000 description 3
- 229910021417 amorphous silicon Inorganic materials 0.000 description 3
- 230000003321 amplification Effects 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 230000005587 bubbling Effects 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 230000007797 corrosion Effects 0.000 description 3
- 238000005260 corrosion Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- -1 fecal samples Substances 0.000 description 3
- 238000002372 labelling Methods 0.000 description 3
- 238000003199 nucleic acid amplification method Methods 0.000 description 3
- 239000002773 nucleotide Substances 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 230000000007 visual effect Effects 0.000 description 3
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- 108020000948 Antisense Oligonucleotides Proteins 0.000 description 2
- 230000003466 anti-cipated effect Effects 0.000 description 2
- 239000000074 antisense oligonucleotide Substances 0.000 description 2
- 238000012230 antisense oligonucleotides Methods 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 238000004166 bioassay Methods 0.000 description 2
- 239000013060 biological fluid Substances 0.000 description 2
- 239000003990 capacitor Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 229910021641 deionized water Inorganic materials 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 238000006073 displacement reaction Methods 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 238000003487 electrochemical reaction Methods 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 238000007824 enzymatic assay Methods 0.000 description 2
- 210000000416 exudates and transudate Anatomy 0.000 description 2
- 230000005661 hydrophobic surface Effects 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 230000002093 peripheral effect Effects 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 108091033319 polynucleotide Proteins 0.000 description 2
- 102000040430 polynucleotide Human genes 0.000 description 2
- 239000002157 polynucleotide Substances 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 238000000734 protein sequencing Methods 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- 238000007493 shaping process Methods 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 239000010409 thin film Substances 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 230000007704 transition Effects 0.000 description 2
- 230000014616 translation Effects 0.000 description 2
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 1
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- ASJSAQIRZKANQN-CRCLSJGQSA-N 2-deoxy-D-ribose Chemical compound OC[C@@H](O)[C@@H](O)CC=O ASJSAQIRZKANQN-CRCLSJGQSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 238000010356 CRISPR-Cas9 genome editing Methods 0.000 description 1
- 108020004635 Complementary DNA Proteins 0.000 description 1
- 108020004394 Complementary RNA Proteins 0.000 description 1
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 1
- 125000000824 D-ribofuranosyl group Chemical group [H]OC([H])([H])[C@@]1([H])OC([H])(*)[C@]([H])(O[H])[C@]1([H])O[H] 0.000 description 1
- 238000001712 DNA sequencing Methods 0.000 description 1
- 208000033999 Device damage Diseases 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 208000005228 Pericardial Effusion Diseases 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 108700005078 Synthetic Genes Proteins 0.000 description 1
- 239000004809 Teflon Substances 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000003929 acidic solution Substances 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 239000012080 ambient air Substances 0.000 description 1
- 210000004381 amniotic fluid Anatomy 0.000 description 1
- 230000000692 anti-sense effect Effects 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- 210000003567 ascitic fluid Anatomy 0.000 description 1
- 238000000429 assembly Methods 0.000 description 1
- 230000000712 assembly Effects 0.000 description 1
- 239000003637 basic solution Substances 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 238000010256 biochemical assay Methods 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 238000010804 cDNA synthesis Methods 0.000 description 1
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 1
- 238000001311 chemical methods and process Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 239000003184 complementary RNA Substances 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 239000003989 dielectric material Substances 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 230000002550 fecal effect Effects 0.000 description 1
- 239000010408 film Substances 0.000 description 1
- 239000008246 gaseous mixture Substances 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 238000010362 genome editing Methods 0.000 description 1
- 229920006158 high molecular weight polymer Polymers 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 230000003100 immobilizing effect Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000012212 insulator Substances 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 239000002608 ionic liquid Substances 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 238000002032 lab-on-a-chip Methods 0.000 description 1
- 239000004973 liquid crystal related substance Substances 0.000 description 1
- 230000001926 lymphatic effect Effects 0.000 description 1
- 239000006249 magnetic particle Substances 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 229910044991 metal oxide Inorganic materials 0.000 description 1
- 150000004706 metal oxides Chemical class 0.000 description 1
- 238000001690 micro-dialysis Methods 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 239000002777 nucleoside Substances 0.000 description 1
- 150000003833 nucleoside derivatives Chemical class 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 210000003463 organelle Anatomy 0.000 description 1
- 238000010647 peptide synthesis reaction Methods 0.000 description 1
- 210000004912 pericardial fluid Anatomy 0.000 description 1
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 210000004910 pleural fluid Anatomy 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 238000009877 rendering Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 238000000518 rheometry Methods 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 210000004911 serous fluid Anatomy 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 210000001179 synovial fluid Anatomy 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 210000001138 tear Anatomy 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000008016 vaporization Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 210000005253 yeast cell Anatomy 0.000 description 1
Images
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
- B01L3/502769—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by multiphase flow arrangements
- B01L3/502784—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by multiphase flow arrangements specially adapted for droplet or plug flow, e.g. digital microfluidics
- B01L3/502792—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by multiphase flow arrangements specially adapted for droplet or plug flow, e.g. digital microfluidics for moving individual droplets on a plate, e.g. by locally altering surface tension
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
- B01L3/502715—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by interfacing components, e.g. fluidic, electrical, optical or mechanical interfaces
-
- G—PHYSICS
- G02—OPTICS
- G02B—OPTICAL ELEMENTS, SYSTEMS OR APPARATUS
- G02B26/00—Optical devices or arrangements for the control of light using movable or deformable optical elements
- G02B26/004—Optical devices or arrangements for the control of light using movable or deformable optical elements based on a displacement or a deformation of a fluid
- G02B26/005—Optical devices or arrangements for the control of light using movable or deformable optical elements based on a displacement or a deformation of a fluid based on electrowetting
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2200/00—Solutions for specific problems relating to chemical or physical laboratory apparatus
- B01L2200/06—Fluid handling related problems
- B01L2200/0621—Control of the sequence of chambers filled or emptied
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2200/00—Solutions for specific problems relating to chemical or physical laboratory apparatus
- B01L2200/06—Fluid handling related problems
- B01L2200/0673—Handling of plugs of fluid surrounded by immiscible fluid
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2200/00—Solutions for specific problems relating to chemical or physical laboratory apparatus
- B01L2200/14—Process control and prevention of errors
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2200/00—Solutions for specific problems relating to chemical or physical laboratory apparatus
- B01L2200/16—Reagents, handling or storing thereof
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/06—Auxiliary integrated devices, integrated components
- B01L2300/0627—Sensor or part of a sensor is integrated
- B01L2300/0645—Electrodes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/08—Geometry, shape and general structure
- B01L2300/0809—Geometry, shape and general structure rectangular shaped
- B01L2300/0816—Cards, e.g. flat sample carriers usually with flow in two horizontal directions
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2400/00—Moving or stopping fluids
- B01L2400/04—Moving fluids with specific forces or mechanical means
- B01L2400/0403—Moving fluids with specific forces or mechanical means specific forces
- B01L2400/0415—Moving fluids with specific forces or mechanical means specific forces electrical forces, e.g. electrokinetic
- B01L2400/0427—Electrowetting
Definitions
- Digital microfluidic (DMF) devices use independent electrodes to propel, split, and join droplets in a confined environment, thereby providing a “lab-on-a-chip.”
- Digital microfluidic devices have been used to actuate a wide range of volumes (nanoliter nL to microliter ⁇ L) and are alternatively referred to as electrowetting on dielectric, or “EWoD,” to further differentiate the method from competing microfluidic systems that rely on electrophoretic flow and/or micropumps.
- electrowetting a continuous or pulsed electrical signal is applied to a droplet, leading to switching of its contact angle.
- Liquids capable of electrowetting a hydrophobic surface typically include a polar solvent, such as water or an ionic liquid, and often feature ionic species, as is the case for aqueous solutions of electrolytes.
- a polar solvent such as water or an ionic liquid
- ionic species as is the case for aqueous solutions of electrolytes.
- EWoD digital microfluidic devices There are two main architectures of EWoD digital microfluidic devices, i.e., open and closed systems. Often, both EWoD configurations include a bottom plate featuring a stack of propulsion electrodes, an insulator dielectric layer, and a hydrophobic layer providing a working surface. However, closed systems also feature a top plate parallel to the bottom plate and including a top electrode serving as common counter electrode to all the propulsion electrodes. The top and bottom plates are provided in a spaced relationship defining a microfluidic region to permit droplet motion within the microfluidic region under application of propulsion voltages between the bottom electrode array and the top electrode.
- each pixel of the DMF receives a voltage pulse (i.e., a voltage differential between the two electrodes associated with that pixel) or temporal series of voltage pulses (i.e., a “waveform” or “drive sequence” or “driving sequence”) in order to effect a transition from one electrowetting state of the pixel to another.
- a voltage pulse i.e., a voltage differential between the two electrodes associated with that pixel
- temporal series of voltage pulses i.e., a “waveform” or “drive sequence” or “driving sequence”
- the electrodes of an AM-EWoD are often switched by a transistor matrix, such as thin-film transistors (TFTs), although electro-mechanical switches may also be used.
- TFT-based thin film electronics may be used to control the addressing of voltage pulses to an EWoD array by using circuit arrangements very similar to those employed in AM display technologies.
- TFT arrays are highly desirable for this application, due to having thousands of addressable pixels, thereby allowing mass parallelization of droplet procedures.
- Driver circuits can be integrated onto the AM-EWoD array substrate, and TFT-based electronics are well suited to the AM-EWoD application.
- an electrowetting system for actuating droplets of a first composition and droplets of a second composition.
- the system includes: a plurality of electrodes configured to manipulate droplets of fluid in a microfluidic space, wherein each electrode is coupled to circuitry configured to selectively apply driving voltages to the electrode; and a processing unit operably connected to a storage medium, which may include a look up table (LUT) correlating drive sequences to chemical species and at least one composition parameter.
- LUT look up table
- the processing unit is configured or programmed to: receive input data of a first chemical species and a first composition parameter of the first composition; receive input data of a second chemical species and a second composition parameter of the second composition; correlate a first drive sequence with the first chemical species and the first composition parameter; correlate a second drive sequence with the second chemical species and the second composition parameter; and output the first drive sequence and the second drive sequence to the plurality of electrodes.
- a method for performing droplet operations on a first composition and a second composition in an electrowetting system comprises: a plurality of electrodes configured to manipulate droplets of fluid in a microfluidic space, wherein each electrode is coupled to circuitry configured to selectively apply driving voltages to the electrode; and a processing unit operably connected to a storage medium, which may include a look up table (LUT) correlating drive sequences to chemical species and composition parameters.
- LUT look up table
- the method comprises: receiving input data of a first chemical species and a first composition parameter of the first composition; receiving input data of a second chemical species and a second composition parameter of the second composition; correlating a first drive sequence with the first chemical species and first composition parameter of the first composition; correlating a second drive sequence with the second chemical species and second composition parameter of the second composition; and outputting the first drive sequence and the second drive sequence to the plurality of electrodes.
- an electrowetting system for actuating a mixed droplet, the system including: a plurality of electrodes configured to manipulate droplets of fluid in a microfluidic space, wherein each electrode is coupled to circuitry configured to selectively applying driving voltages to the electrode; and a processing unit operably connected to a look up table (LUT) correlating drive sequences to chemical species and at least one composition parameter.
- LUT look up table
- the processing unit is configured or programmed to: provide a first droplet with a first composition, a first volume, and a first composition parameter, wherein at least one of the first composition, first volume, and first composition parameter is correlated with a first drive sequence for the electrowetting system; provide a second droplet with a second composition, a second volume, and a second composition parameter, wherein at least one of the second composition, second volume, and second composition parameter is correlated with a second drive sequence for the electrowetting system; mix the first droplet and the second droplet to create a mixed droplet; and drive the mixed droplet with a third drive sequence that is a predetermined weighted average of the first drive sequence and the second drive sequence.
- an electrowetting system for actuating droplets of at least one composition
- the system including: a plurality of electrodes configured to manipulate droplets of fluid in a microfluidic space, wherein each electrode is coupled to circuitry configured to selectively apply driving voltages to the electrode; and a processing unit operably connected to a look up table (LUT) correlating drive sequences to chemical species and at least one composition parameter, the processing unit being configured or programmed to: receive input data of a chemical species and a composition parameter of the at least one composition; correlate a drive sequence with the chemical species and the composition parameter; and output the drive sequence to the plurality of electrodes.
- LUT look up table
- an electrowetting system for actuating droplets of at least one composition
- the system including: a plurality of electrodes configured to manipulate droplets of fluid in a microfluidic space, wherein each electrode is coupled to circuitry configured to selectively apply driving voltages to the electrode; and a processing unit operably connected to a storage medium, which may include a look up table (LUT) correlating drive sequences to composition identifying data, the processing unit being configured to: receive input data identifying the at least one composition; correlate a drive sequence with the data identifying the at least one composition; and output the drive sequence to the plurality of electrodes, to actuate a droplet of the at least one composition.
- LUT look up table
- FIG. 1 A is a diagrammatic cross-section of the cell of an example EWoD device.
- FIG. 1 B illustrates EWoD operation with DC Top Plane.
- FIG. 1 C illustrates EWoD operation with top plane switching (TPS).
- FIG. 1 D is a schematic diagram of a TFT connected to a gate line, a source line, and a propulsion electrode.
- FIG. 2 is a schematic illustration of an exemplary TFT backplane controlling droplet operations in an AM-EWoD propulsion electrode array.
- FIG. 3 A is a diagram schematically illustrating a system for storing and retrieving any number of reagent-specific drive schemes.
- FIG. 3 B is the flowchart of an exemplary method for correlating input droplet data to drive sequences to be output to DMF electrodes.
- FIG. 3 C is an exemplary set of drive sequences each specifically suited to a class of droplet composition.
- FIG. 4 illustrates a charge-neutral pulse sequence
- FIG. 5 illustrates a non-impulse-balanced pulse sequence
- FIG. 6 illustrates a pulse sequence with a correcting, balancing pulse.
- FIG. 7 shows a simple three-pixel neck actuated off a reservoir to cleave off a droplet.
- FIG. 8 shows the formation of a neck two droplet diameters in length in order to successfully break off the droplet.
- FIG. 9 schematically illustrates a droplet mixing pattern.
- FIG. 10 A shows the first step of a droplet mixing pattern.
- FIG. 10 B shows the droplet of FIG. 10 A after an elongating drive sequence is applied.
- FIG. 10 C illustrates the creation of an example weighted average drive sequence.
- FIG. 11 includes the flow chart of a method of using drive profiles according to an exemplary embodiment.
- FIG. 12 is a schematic illustration of drive sequences having different intermittency values.
- FIG. 13 A is a top view of a DMF device.
- FIG. 13 B is the DMF of FIG. 13 A pictured after about 1 hour of operation.
- FIG. 13 C is a picture taken after about 6 hours of operation.
- FIG. 13 D is a picture taken after about 24 hours of operation.
- FIG. 13 E is a picture taken after about 25 hours of operation.
- FIG. 14 is a top view of the DMF device of FIGS. 13 A- 13 E after testing two different dispensing schemes.
- FIG. 15 is a block diagram of an exemplary computing device that can be used to perform one or more steps of the methods provided by exemplary embodiments.
- Actuate” or “activate” with reference to one or more electrodes means effecting a change in the electrical state of the one or more electrodes which, in the presence of a droplet, results in a manipulation of the droplet.
- Activation of an electrode can be accomplished using alternating current (AC) or direct current (DC). Where an AC signal is used, any suitable frequency may be employed.
- Droplet means a volume of liquid that electrowets a hydrophobic surface and is at least partially bounded by carrier fluid and/or, in some instances, a gas or gaseous mixture such as ambient air.
- a droplet may be completely surrounded by carrier fluid or may be bounded by carrier fluid and one or more surfaces of an EWoD device.
- Droplets may take a wide variety of shapes; non-limiting examples include generally disc shaped, slug shaped, truncated sphere, ellipsoid, spherical, partially compressed sphere, hemispherical, ovoid, cylindrical, and various shapes formed during droplet operations, such as merging or splitting or formed as a result of contact of such shapes with one or more working surface of an EWoD device.
- Droplets may include typical polar fluids such as water, as is the case for aqueous or non-aqueous compositions, or may be mixtures or emulsions including aqueous and non-aqueous components. Droplets may also include dispersions and suspensions, for example magnetic beads in an aqueous solvent.
- a droplet may include a biological sample, such as whole blood, lymphatic fluid, serum, plasma, sweat, tear, saliva, sputum, cerebrospinal fluid, amniotic fluid, seminal fluid, vaginal excretion, serous fluid, synovial fluid, pericardial fluid, peritoneal fluid, pleural fluid, transudates, exudates, cystic fluid, bile, urine, gastric fluid, intestinal fluid, fecal samples, liquids containing single or multiple cells, liquids containing organelles, fluidized tissues, fluidized organisms, liquids containing multi-celled organisms, biological swabs and biological washes.
- a biological sample such as whole blood, lymphatic fluid, serum, plasma, sweat, tear, saliva, sputum, cerebrospinal fluid, amniotic fluid, seminal fluid, vaginal excretion, serous fluid, synovial fluid, pericardial fluid, peritoneal fluid, pleural fluid, transudates, ex
- a droplet may include one or more reagent, such as water, deionized water, saline solutions, acidic solutions, basic solutions, detergent solutions and/or buffers.
- reagents such as a reagent for a biochemical protocol, a nucleic acid amplification protocol, an affinity-based assay protocol, an enzymatic assay protocol, a gene sequencing protocol, a protein sequencing protocol, and/or a protocol for analyses of biological fluids.
- reagents include those used in biochemical synthetic methods, such as a reagent for synthesizing oligonucleotides finding applications in molecular biology and medicine, nucleic acid molecules.
- the oligonucleotides may contain natural or chemically modified bases and are most commonly used as antisense oligonucleotides, small interfering therapeutic RNAs (siRNA) and their bioactive conjugates, primers for DNA sequencing and amplification, probes for detecting complementary DNA or RNA via molecular hybridization, tools for the targeted introduction of mutations and restriction sites in the context of technologies for gene editing such as CRISPR-Cas9, and for the synthesis of artificial genes.
- the droplet contents may include reagents for peptide and protein production, for example by chemical synthesis, expression in living organisms such as bacteria or yeast cells or by the use of biological machinery in in vitro systems.
- DMF device EWoD device
- Droplet actuator mean a device for manipulating droplets.
- droplet actuators see Pamula et al., U.S. Pat. No. 6,911,132, entitled “Apparatus for Manipulating Droplets by Electrowetting-Based Techniques,” issued on Jun. 28, 2005; Pamula et al., U.S. Patent Pub. No. 20060194331, entitled “Apparatuses and Methods for Manipulating Droplets on a Printed Circuit Board,” published on Aug. 31, 2006; Pollack et al., International Patent Pub. No. WO/2007/120241, entitled “Droplet-Based Biochemistry,” published on Oct.
- Droplet operation means any manipulation of one or more droplets on a microfluidic device.
- a droplet operation may, for example, include: loading a droplet into the DMF device; dispensing one or more droplets from a source reservoir; splitting, separating or dividing a droplet into two or more droplets; moving a droplet from one location to another in any direction; merging or combining two or more droplets into a single droplet; diluting a droplet; mixing a droplet; agitating a droplet; deforming a droplet; holding a droplet in position; incubating a droplet; heating a droplet; vaporizing a droplet; cooling a droplet; disposing of a droplet; transporting a droplet out of a microfluidic device; other droplet operations described herein; and/or any combination of the foregoing.
- merge “merge,” “merging,” “combine,” “combining” and the like are used to describe the creation of one droplet from two or more droplets. It should be understood that when such a term is used in reference to two or more droplets, any combination of droplet operations that are sufficient to result in the combination of the two or more droplets into one droplet may be used. For example, “merging droplet A with droplet B,” can be achieved by transporting droplet A into contact with a stationary droplet B, transporting droplet B into contact with a stationary droplet A, or transporting droplets A and B into contact with each other.
- splitting is not intended to imply any particular outcome with respect to volume of the resulting droplets (i.e., the volume of the resulting droplets can be the same or different) or number of resulting droplets (the number of resulting droplets may be 2, 3, 4, 5 or more).
- mixing refers to droplet operations which result in more homogenous distribution of one or more components within a droplet. Examples of “loading” droplet operations includes but is not limited to microdialysis loading, pressure assisted loading, robotic loading, passive loading, and pipette loading. Droplet operations may be electrode-mediated. In some cases, droplet operations are further facilitated by the use of hydrophilic and/or hydrophobic regions on surfaces and/or by physical obstacles.
- Gate driver is a device directing a high-current drive input for the gate of a high-power transistor such as a TFT coupled to an EWoD pixel electrode.
- Source driver is a device directing a high-current drive input for the source of a high-power transistor.
- Topic plane common electrode driver is a power amplifier producing a high-current drive input for the top plane electrode of an EWoD device.
- Drive sequence denotes the entire voltage against time curve used to actuate a pixel in a microfluidic device.
- a sequence will comprise a plurality of elements; where these elements are essentially rectangular (i.e., where a given element comprises application of a constant voltage for a period of time), the elements may be called “voltage pulses” or “drive pulses”.
- drive scheme denotes a set of one or more drive sequences sufficient to effect one or more manipulations on one or more droplets in the course of a given droplet operation.
- frame denotes a single update of all the pixel rows in a microfluidic device.
- Nucleic acid molecule is the overall name for DNA or RNA, either single- or double-stranded, sense or antisense. Such molecules are composed of nucleotides, which are the monomers made of three moieties: a 5-carbon sugar, a phosphate group and a nitrogenous base. If the sugar is a ribosyl, the polymer is RNA (ribonucleic acid); if the sugar is derived from ribose as deoxyribose, the polymer is DNA (deoxyribonucleic acid).
- Nucleic acid molecules vary in length, ranging from oligonucleotides of about 10 to 25 nucleotides which are commonly used in genetic testing, research, and forensics, to relatively long or very long prokaryotic and eukaryotic genes having sequences in the order of 1,000, 10,000 nucleotides or more.
- Their nucleotide residues may either be all naturally occurring or at least in part chemically modified, for example to slow down in vivo degradation. Modifications may be made to the molecule backbone, e.g. by introducing nucleoside organothiophosphate (PS) nucleotide residues.
- PS nucleoside organothiophosphate
- Another modification that is useful for medical applications of nucleic acid molecules is 2′ sugar modifications.
- Modifying the 2′ position sugar is believed to increase the effectiveness of therapeutic oligonucleotides by enhancing their target binding capabilities, specifically in antisense oligonucleotides therapies.
- Two of the most commonly used modifications are 2′-O-methyl and the 2′-Fluoro.
- a liquid in any form e.g., a droplet or a continuous body, whether moving or stationary
- a liquid in any form e.g., a droplet or a continuous body, whether moving or stationary
- such liquid could be either in direct contact with the electrode/array/matrix/surface, or could be in contact with one or more layers or films that are interposed between the liquid and the electrode/array/matrix/surface.
- a droplet is described as being “in”, “on”, or “loaded on” a microfluidic device, it should be understood that the droplet is arranged on the device in a manner which facilitates using the device to conduct one or more droplet operations on the droplet, the droplet is arranged on the device in a manner which facilitates sensing of a property of or a signal from the droplet, and/or the droplet has been subjected to a droplet operation on the droplet actuator.
- Each when used in reference to a plurality of items, is intended to identify an individual item in the collection but does not necessarily refer to every item in the collection. Exceptions can occur if explicit disclosure or context clearly dictates otherwise.
- the present application relates to novel, adaptable EWoD devices which are programmed to individually tailor their drive schemes to different droplet contents and other variables. Also provided are programmable processing and control units for operating the devices. From an operational standpoint, the data processing steps associated with this novel approach usually include: (i) determining which pixels are occupied by droplets; (ii) ascertaining which composition of matter occupies the area of one or more pixels, and (iii) what types of pulse sequences, if any, are to be applied to the droplets. As such, the voltage and duration of each driving pulse may be chosen on the basis of variables including droplet composition, droplet location on the array, and the operation to be performed.
- the ability to adjust the way a droplet is handled to suit a variety of chemical and biological reagents and products enables the device to bring to completion each desired droplet operation.
- the invention is applicable to either open or closed architectures and may be implemented in segmented and active matrix devices alike, including but not only AM-EWoD systems where the transistors of the matrix are TFT.
- the device is used to perform a number of different chemical or biological assays and is provided with access to memory storing programmable instructions specifically suited to each of the reagent compositions used in each of the assays.
- FIG. 1 A shows a diagrammatic cross-section of the cell in an example traditional closed electrowetting on dielectric EWoD device 100 where droplet 104 is surrounded on the sides by carrier fluid 102 and sandwiched between top hydrophobic layer 107 and bottom hydrophobic layer 110 .
- Propulsion electrodes 105 can be directly driven or switched by transistor arrays 108 arranged to be driven with data (source) and gate (select) lines, much like an active matrix in liquid crystal displays (LCDs) and organic light emitting diodes (OLEDs), resulting in what is known as active matrix (AM) electrowetting on dielectric EWoD.
- Typical cell spacing is usually in the range of about 50 microns ( ⁇ m) to about 500 ⁇ m.
- FIG. 1 B illustrates EWOD operation in DC Top Plane mode, where the top plane electrode 106 is set to a potential of zero volts, for example by grounding.
- the potential applied across the cell is the voltage on the active pixel, that is, pixel 101 having a different voltage to the top plane so that conductive droplets are attracted to the electrode.
- FIG. 1 C shows driving the cell with TPS, in which case the driving voltage is doubled to ⁇ 30 V by powering the top electrode out of phase with active pixels, such that the top plane voltage is additional to the voltage supplied by the TFT.
- the device additionally includes a dielectric layer 108 between the pixel electrodes 105 and the top hydrophobic layer 107 .
- Amorphous silicon TFT plates usually have only one transistor per pixel, although configurations having two or more transistors are also contemplated.
- the transistor is connected to a gate line, a source line (also known as “data line”), and a propulsion electrode.
- a gate line also known as “data line”
- data line also known as “data line”
- Vg “ON” the impedance between the source line and pixel
- Vg “OFF” the TFT is high impedance and voltage is stored on the pixel storage capacitor and not affected by the voltage on the source line as the other pixels are addressed
- the TFT should act as a digital switch. In practice, there is still a certain amount of resistance when the TFT is in the “ON” setting, so the pixel takes time to charge. Additionally, voltage can leak from Vs to Vp when the TFT is in the “OFF” setting, causing cross-talk. Increasing the capacitance of the storage capacitor C s reduces cross-talk, but at the cost of rendering the pixels harder to charge.
- the drivers of a TFT array receive instructions relating to droplet operations from a processing unit.
- the processing unit may be, for example, a general purpose computer, special purpose computer, personal computer, or other programmable data processing apparatus providing processing capabilities, such as storing, interpreting, and/or executing software instructions, as well as controlling the overall operation of the device.
- the processing unit is coupled to a memory which includes programmable instructions to direct the processing unit to perform various operations, such as, but not limited to, providing the TFT drivers with input instructions directing them to generate electrode drive signals in accordance with embodiments herein.
- the memory may be physically located in the DMF device or in a computer or computer system which is interfaced to the device and hold programs and data that are part of a working set of one or more tasks being performed by the device.
- the memory may store programmable instructions to carry out the drive schemes described in connection with a set of droplet operations.
- the processing unit executes the programmable instructions to generate control inputs that are delivered to the drivers to implement one or more drive schemes associated with a given droplet operation.
- FIG. 2 is a diagrammatic view of an exemplary TFT backplane controlling droplet operations in an AM-EWoD propulsion electrode array.
- the elements of the EWoD device are arranged in the form of a matrix as defined by the source lines and the gate lines of the TFT array.
- the source line drivers provide the source levels corresponding to a droplet operation.
- the gate line drivers provide the signals for opening the transistor gates of electrodes which are to be actuated in the course of the operation. The figure shows the signals lines only for those data lines and gate lines shown in the figure.
- the gate line drivers may be integrated in a single integrated circuit.
- the data line drivers may be integrated in a single integrated circuit.
- the integrated circuit may include the complete gate and source driver assemblies together with a controller.
- controller/driver chips include those commercialized by Ultrachip Inc. (San Jose, California), such as UC8152, a 480-channel gate/source programmable driver.
- the matrix of FIG. 2 is made of 1024 source lines and a total of 768 gate lines, although either number may change to suit the size and spatial resolution of the DMF device.
- Each element of the matrix contains a TFT of the type illustrated in FIG. 1 D for controlling the potential of a corresponding pixel electrode, and each TFT is connected to one of the gate lines and one of the source lines.
- this application relates to adaptable DMF devices programmed to implement sets of drive schemes which are specifically tailored to individually suit one or more of any number of differing droplet compositions and composition parameters.
- FIG. 3 A is a block diagram schematically illustrating an example system for storing reagent-specific drive schemes.
- the example system in FIG. 3 A may be implemented in more detail with respect to FIG. 15 .
- the processing unit is operatively coupled to a memory in which a searchable lookup table or other searchable data structure is held.
- the memory stores reagent-specific drive profiles are stored.
- the memory can also store programmable instructions executed by the processing unit to carry out operations described herein.
- Each profile includes one or more drive schemes which may be specifically tailored to the properties of a given reagent.
- the term “reagent-specific drive profile” extends to profiles applicable to any composition manipulated in the DMF device, including a reagent at a particular concentration, a mixture of two or more reagents, and/or one or more reaction products. Included in the lookup table may also be one or more tuning functions or tables for adapting the drive schemes of a profile to suit the temperature of the DMF device or any of its parts, ambient humidity, and other extrinsic variables which may affect droplet operations. Other reagent-specific drive profiles may depend upon, e.g., the type of carrier fluid, the pH of the reagent, viscosity of the reagent, or the ionic concentration of the reagent.
- the lookup table may be held in a file system or located in virtual memory associated with one or more computer systems and may be arranged in a variety of ways, such as physically located inside the computer system, directly attached to the CPU bus, attached to a peripheral bus, or located in a cloud-based storage platform that is operably connected to the computer system.
- a suitable reagent-specific profile is chosen from among those available within the table.
- a reagent-specific profile may include composition parameters such as pH, temperature, rheological properties such as viscosity, ionic strength, electrical conductivity, and absorbance at particular wavelengths, among other parameters relevant to the electrowetting response of the corresponding reagent.
- drive schemes from the profile or relevant portions thereof may be loaded into a temporary memory for subsequent use by the processing unit.
- the mobility of a droplet in a microfluidic space is affected by parameters including but not limited to: reagent concentration in the droplet solvent, e.g. water, ionic strength, concentration and chemistry of surfactant additives, droplet rheology, reagent charge which in turn may be affected by the pH of the droplet, and temperature or temperature gradients within the device.
- reagent concentration in the droplet solvent e.g. water
- ionic strength concentration and chemistry of surfactant additives
- droplet rheology e.g. water
- reagent charge which in turn may be affected by the pH of the droplet
- temperature or temperature gradients within the device e.g., reagent charge
- these and other properties may be measured for each reagent type and a determination made as to which drive profile, typically, will be best suited to a given reagent or mixture.
- droplets of the reagent may be directly tested on a DMF device by applying each of the available drive profiles until the profile with the acceptable performance (e.g., the best performance) is found and labelled with a code or other identifying data matching the profile to the reagent for future use. Thereafter, for all subsequent manipulations of the reagent in the DMF device, a user can specify which drive profile is to be used at a particular location in the device.
- the acceptable performance e.g., the best performance
- FIG. 3 B is a flowchart illustrating an example method 300 for operating an electrowetting system with the sequence drives saved to the reagent-specific drive profiles.
- the method 300 can be performed using the processing unit of the electrowetting system.
- the processing unit receives droplet data.
- the processing unit receives data pertaining to the characteristics of a droplet to be actuated in the system.
- the data usually includes the identity of chemicals species contained in the droplet, e.g., one or more reagents delivered in the droplet, the respective concentrations of relevant chemical species, and/or other composition parameters related to a chemical species concentration or affecting droplet mobility and chemistry, for example pH, temperature, rheological properties such as viscosity, ionic strength, electrical conductivity, and absorbance at particular wavelengths.
- the processing unit searches reagent-specific profiles in the look up table.
- the processing unit correlates relevant droplet data, such as which reagent chemical species it contains and their respective concentrations, to one or more drive sequences.
- the processing unit outputs the drive sequences to the electrodes of the electrowetting system.
- Droplets of each reagent may be actuated with drive sequences specifically suited to their characteristics. This novel capability is especially advantageous because implementing the same drive scheme for different chemical compositions may result in sub-optimal droplet actuation on one or more of the compositions.
- voltage ranges and impulse lengths suitable for one composition may induce undesired electrochemical reactions in another. This in turn may lead to further reactions leading to corrosion of the working surfaces of the DMF device.
- Drive Scheme A performs satisfactorily when applied to a first Reagent 1 but leads to corrosion on the working surfaces when applied to a second Reagent 2 .
- a complete reagent drive profile is custom-made for each individual reagent type and added to the look up table.
- Each reagent is run through moving, splitting, dispensing, mixing and holding tests spanning a broad set of voltages, polarities, and pulse durations to identify drive schemes having pulse sequences best suited to that reagent.
- This customized reagent profile is then be added to the look up table and matched to one or more reagents by a code or other labelling item of information, to be called by the processing unit whenever that reagent is to be used on the DMF device.
- the number of reagent (and, as explained above, any mixtures of two or more reagents and/or products) profiles stored in the look up table would then be up to the number of reagents or mixtures that have reagent drive profiles determined therefor.
- a user may specify a code or other labeling item of information associated with which reagent is to be used at a particular location in the DMF device.
- suitable drive profiles are already well-known and no data regarding chemical species or composition parameters are required for selecting appropriate drive sequences.
- a typical example is provided by standardized buffered aqueous solutions serving as solvents and other roles in biochemical or biomolecular applications, e.g., nucleic acid amplification, affinity-based assays, enzymatic assays, gene sequencing, protein sequencing, peptide and protein synthesis, and/or analyses of biological fluids, where the buffers are typical sourced in bulk from commercial providers.
- more simple and expedited processing may be achieved by marking or labeling a standardized composition with a code or other identifying data matching the composition to a pre-selected drive profile in the look up table.
- the processing unit correlates the identifying data to one or more drive sequences in the pre-selected drive profile.
- the processing unit searches the look up table for drive profiles and select drive sequences fitting the chemical species and parameters of the standardized composition.
- FIG. 11 includes the flow chart ( 1100 ) of a method of using the drive profiles according to an exemplary embodiment.
- the method 1100 can be performed using an electrowetting system
- the processing unit of the electrowetting system receives a desired droplet operation (e.g., from a user input).
- the processing unit is programmed to search for and identify applicable reagent profiles in the look up table.
- the processing unit extracts drive schemes. For example, the processing unit is programmed to select from the profiles one or more drive schemes which are best-suited to the compositions, e.g., reagents, products, and/or mixtures, which are to be manipulated in the operation.
- the processing unit forms a drive protocol.
- the processing unit combines the drive sequences of the schemes together to form a driving protocol that is executed to implement the droplet operation.
- the processing unit calculates drive variables. For example, the processing unit calculates drive variables relating to the drive sequences such as the polarity, frequency, and amplitude of each of the pulses of the corresponding voltage sequences are calculated).
- the processing unit outputs instructions to a controller.
- the controller of the electrowetting system outputs signals to the drivers
- the drivers of the electrowetting system drives pixel electrodes. For example, the drivers drive the pixel electrodes by affecting a voltage at particular pixel electrodes as a function of time.
- a given droplet operation may require drive schemes of differing levels of complexity depending on the number of manipulations associated with that droplet operation.
- Typical droplet operations include those outlined above, namely: loading a droplet into the DMF device; dispensing one or more droplets from a reservoir; splitting, separating or dividing a droplet into two or more droplets; moving a droplet from one location to another in any direction; merging or combining two or more droplets into a single droplet; diluting a droplet; mixing a droplet; agitating a droplet; deforming a droplet; holding a droplet in position; incubating a droplet; heating a droplet; cooling a droplet; disposing of a droplet; transporting a droplet out of a DMF device; and/or any combination of the foregoing.
- a drive scheme may include any from just one to a large number of drive sequences, depending on the requirements and complexity of the operation. In some instances, it may be preferable to store multiple sets of drive sequence data to allow for variations in environmental variables such as temperature and humidity. Alternatively, a drive scheme may include tuning functions which are applied to change one or more coefficients defining its drive sequences to suit different environmental conditions.
- an exemplary drive scheme hereinafter referred to as “motion scheme”, which is implemented in a DMF device for moving droplets of a given composition from one location to another.
- the scheme includes one or more drive sequences specifying the magnitude, duration, polarity, and other relevant characteristics of pulses that are applied to actuate composition droplets.
- Other relevant data may also be included in the scheme, for example the speed of movement of the pixels, meaning how quickly the applied voltage profile moves from one set of pixels currently occupied by the droplet to an adjacent set of pixels currently unoccupied by the droplet, where the droplet will move to next and how quickly to change the voltage on the trailing edge of the droplet to force the droplet off the previous location.
- a motion scheme for deionized water with a surfactant for example 0.05 wt % TWEEN® 20, includes a simple 50 Hz square wave alternating pulse sequence at +/ ⁇ 30 V.
- the pulse sequence may be generated on a TFT array and top plane switching (TPS) to reverse the polarity.
- the application of drive pulses to a pixel may result in deleterious side effects resulting from the accumulation of residual charge on the pixel surface which is apt to cause unwanted electrochemical reactions and/or surface and electrode degradation.
- One approach that may be taken for minimizing damage to the EWoD device involves ensuring that a given drive scheme is charge-neutral, in the sense that, for any arbitrary series of pulses in a drive scheme, the overall change in charge surface density is equal to zero. When the overall drive scheme of a droplet operation is charge-neutral, and even more when all drive sequences of the scheme are each individually charge-neutral, the chance for electrochemical damage to the pixel surface and the underlying electrodes is minimized.
- charge neutrality may be attempted by ensuring that a given drive scheme is “impulse-balanced” in the sense that, for any arbitrary series of pulses in a drive sequence belonging to the scheme, the overall applied impulse (i.e., the integral of the applied voltage with respect to time) equals zero.
- the overall applied impulse i.e., the integral of the applied voltage with respect to time
- FIG. 4 where the number and duration of positive and negative pulses are equal.
- the impulse in the device where the number and duration of pulses may not be the same but the sum of the products of the voltage and duration for each positive pulse is equal to the same sum of products for the negative driving pulses.
- impulse-balanced pulses may not be charge-neutral in that they still leave residual charges on the surface due to asymmetric effects of positive- and negative-voltage pulses.
- additional positive or negative correcting pulses beyond impulse balance may be applied to obtain charge balance on the surface.
- a first attempt is made by applying an impulse-balanced drive scheme followed by measuring the amount of residual surface charge by one of the methods known to those skilled in the art. If unacceptable surface charge densities are detected, corrective pulses may be added in further iterations until charge balance is reached, thereby creating an impulse-imbalanced, yet charge-neutral drive sequence. This approach ensures that the residual charge experienced by any pixel of the DMF device is null or at least bounded by a known value, regardless of the exact series of transitions undergone by that pixel.
- PWM pulse width modulated
- the negative pulses are the same number as the positive pulses, but longer in duration.
- the net result over time imparts a negative impulse to the pixel surface, as illustrated in FIG. 5 .
- the PWM includes changing the balance of pulses and rests to change the effective impulse over time and may also change the net impulse balance if the frequency of pulses of one polarity is higher than the frequency of the other polarity.
- one or more charge-correcting pulses of the opposite polarity sufficient to remove residual charge partially or fully, may be added to either the beginning of the drive sequence, before the droplet has started to move, or to the end of the sequence, after the droplet has been moved to the new location. This type of simple correcting pulse is shown in FIG. 6 .
- any correcting pulse can be used and not move the droplet.
- more complex sequences of correcting pulses can be used to create a charge-neutral pulse sequence, and pulses of different voltages can also serve as correcting tools.
- dispensing scheme another exemplary scheme, hereinafter referred to as “dispensing scheme”, is provided for dispensing droplets of a desired reagent from a reservoir.
- This type of schemes are usually characterized by drive sequences of a more complex nature than the aforementioned motion schemes and may require additional information to be fully applicable to each reagent or reagent mixture.
- information on droplet mobility that is derived from motion schemes may still prove useful in selecting drive schemes best suited to dispensing droplets of the same or similar composition.
- a dispensing scheme is applied to move reagent aliquots from a typically large reservoir volume to form an actuated neck.
- a droplet is cleaved off, and the fluid of the neck is returned to the reservoir.
- the length of the actuated neck needed before a drop can be successfully cleaved from the head of the neck may be reagent-dependent.
- the dispensing profile may specify actuated neck lengths expressed in terms of numbers of pixels and durations of time required to elapse before a droplet can be safely assumed to have fully separated from the reservoir. For the aforementioned droplets of water with TWEEN® 20 at a concentration of 0.05 wt %, a neck length of 3 pixels and a time interval of 500 ms are usually sufficient to cleave off the droplet.
- FIG. 7 shows a simple three-pixel neck actuated off a reservoir by actuation of pixel electrodes in a PM-EWOD device.
- the footprint of each droplet usually covers the area of one pixel.
- the process of neck formation is controlled at a resolution of about one pixel diameter.
- This neck length allows a droplet to be cleaved off from the neck head on a segmented DMF device. Hence, it is simpler to measure the length of the actuated neck in terms of approximate number of droplet diameters.
- a simple water with TWEEN® 20 surfactant at a concentration of 0.05 vol % is extended to form a neck on an AM-EWOD device having a TFT array.
- the droplet can be much larger than a single pixel electrode, so there much more flexibility in shaping the neck.
- Different-sized necks may be required depending on the size of the droplet relative to the reservoirs, and other properties of the droplet (e.g., surface tension and viscosity). Accordingly, a TFT architecture typically affords the most flexibility in shaping and tuning the neck as compared to typical segmented/direct drive approaches.
- polynucleotides or other polymeric materials has been found to usually render the droplets more difficult to cleave from the reservoir. This may be addressed by increasing actuated neck lengths and allowing for longer time intervals to ensure that the droplets have been fully cleaved.
- loading schemes for instances where droplets may be directly drawn into the microfluidic space, rather than being cleaved from a reservoir. This is a common way of loading various materials onto the pixel array of a microfluidic device and usually requires pulse sequences which differ from those applied to move droplets between locations within the array.
- the droplets may be pulled into the microfluidic space from the edge of the array or from porting holes in the top plate. If a material is provided in a position physically touching the edge of the array, repeated pulsing of pixels at a location adjacent the edge may be applied to draw droplets over the array.
- reagent-specific “loading schemes” can be specifically tailored to suit diverse reagent compositions.
- the merging of different reagents may result in product droplets having different mobility than the original droplets, so the merging scheme may be required to adapt to such changes in mobility. This may be achieved by including drive schemes which are specifically formulated and optimized for the contents of product droplets.
- homogenous distribution of one or more components within the product droplet may be attained by applying the drive sequences of what is hereinafter referred as a “mixing scheme”.
- the physical mixing of droplets is usually dependent on the reagents contained in the droplets. Variables such as the number of repetitions of the mixing motion pattern, time of mixing, and the elongation of the drops during mixing may be changed to accommodate various reagents.
- merging two droplets of the same reagent may require no mixing scheme at all, no additional time for diffusion, and no elongation of the droplets to cause mixing; at the other extreme, two drops containing solutions of distinct, high molecular weight polymers are likely to require repeated execution of the mixing motion pattern, a long mixing time, and multiple elongations of droplets produced by the mixing.
- the mixing scheme schematically illustrated in FIG. 9 includes two repetitions of a mixing motion pattern whereby a product droplet 90 is subsequently moved to each of the four corners of a square 92 having a diameter approximately twice the length of the droplet diameter.
- Droplet elongation is usually applicable to droplets having a footprint large enough to cover at least four pixels in the DMF device.
- the mixing scheme includes a droplet elongation drive sequence of the type schematically illustrated in FIG. 10 .
- the droplet In the initial stage depicted in FIG. 10 A , the droplet is symmetric in shape and spread over a 2 ⁇ 2 pixel square.
- An elongating drive sequence is applied, stretching the droplet to form a linear configuration one pixel wide and four pixels in length ( FIG. 10 B ).
- a second drive sequence is then applied to restore the original configuration of FIG. 10 A , and the process may be repeated until a satisfactory level of mixing is achieved.
- This approach may be applied to any droplet with a footprint covering a square area n pixels in height and n pixels in length, n being a natural number.
- the elongating drive sequence stretches the droplet to yield a linear arrangement 1 pixel high and n 2 pixels long, followed by a second drive sequence restoring the original, symmetric droplet geometry.
- the process may be repeated until the mixing is complete.
- the merging of droplets containing different reagents may result in product droplets having different mobility than the original droplets.
- the mixing drive sequences may be formed by a weighted averaging of drive sequences correlated to the original reagent droplets. In the representative example of FIG.
- a droplet of a first reagent is merged with a droplet of a second reagent.
- the drive sequence optimized for and applied in the instance of the first reagent features pulses of higher voltage than the second reagent. Following merger, this difference is accounted for by applying a mixing sequence formed by a weighted averaging of the first and second sequences.
- the pulses of the third drive sequence are the same in number and frequency as in the first reagent and second reagent drive sequences.
- the pulse voltages applied in the third sequence are weighted averages of the first and second reagent drive sequences, thereby providing a drive scheme better suited to the mixture.
- weighted averaging may be applied to pulse length and/or frequency, resulting in a mixing sequence differing in pulse length and/or frequency from either or both the first and second sequences.
- a “splitting scheme” which may implemented for splitting a droplet into two or more droplets.
- the term “splitting” is not intended to imply any particular outcome with respect to volume of the resulting droplets (i.e., the volume of the resulting droplets can be the same or different) or number of resulting droplets (the number of resulting droplets may be 2, 3, 4, 5 or more).
- Included in this type of scheme are one or more drive sequences for elongating a droplet within the microfluidic space to form a neck that is severed to yield two product droplets. The separation of different droplet components may result in product droplets having different contents than the original droplet.
- the splitting scheme may involve immobilizing the beads at a single place by application of a magnetic field and splitting the droplet to yield a first product droplet containing the beads and a second product droplet free of beads.
- this process allows for the separation of the compound from other components of the droplet.
- droplets may be held in place and prevented from unwanted drifting by implementing what is hereinafter referred to as a “holding scheme”.
- a holding scheme As no motion is imparted to the droplets, pulse sequences containing an intermittent single pulse of limited duration are usually sufficient.
- a single short negative drive pulse is enough to hold a droplet in place even after the voltage pulse is turned off. The droplet remains held in place until the application of a positive pulse.
- a single pulse at a potential of about ⁇ 30 V for a duration of about 200 ms is sufficient for holding droplets that contain surfactants.
- a constant holding voltage of alternating polarity to avoid device damage from extended DC bias may be required to hold the droplet since a single negative pulse does not typically hold this type of droplet in place.
- the holding voltage may be less than the moving voltage if the controller is capable of applying variable potentials, but could be the same as the movement voltage if that is all that is available in the controller.
- suitable drive sequences may be developed and saved to the look up table.
- a DMF device surface was prepared by depositing metal oxide dielectric material onto a square TFT array 5.61 inches in length followed by a hydrophobic coating of Teflon AF® (Poly [4,5-difluoro-2,2-bis(trifluoromethyl)-1,3-dioxole-co-tetrafluoroethylene], Sigma-Aldrich Inc., St. Louis, Mo.).
- Teflon AF® Poly [4,5-difluoro-2,2-bis(trifluoromethyl)-1,3-dioxole-co-tetrafluoroethylene]
- a first solution of Tris-HCl 0.01 M in water was prepared and brought to pH 4 by addition of a mineral acid.
- a second solution was formed by modifying a portion of the first solution through the addition of TWEEN® 20 (Polyoxyethylene (20) sorbitan monolaurate) to a final concentration of 0.05 wt %.
- Holding schemes were developed and tested on both the first and second solution. Each holding scheme featured intermittent drive sequences where the electrodes under a droplet were first actuated then left idling for the rest of the duration of the hold. As intended herein, the extent of intermittency characterizing a drive sequence is directly proportional to the portion of overall time spent idling. For example, as schematically illustrated in FIG. 12 , a driving sequence having an intermittency value of 2 actuates the electrodes for one half of the duration of the hold while a value of 3 applies to driving sequences where the electrodes are actuated for one third of the duration, and so on.
- FIG. 13 A is a picture of the DMF shortly after time zero (TO), with the first solution loaded in a first reservoir (“No TWEEN® 20”) and the second solution in a second reservoir (“0.05% TWEEN® 20”).
- the first reservoir is loaded with a solution of Tris-HCl 0.01 M in water (“No TWEEN® 20”).
- the second reservoir includes the solution of the first reservoir modified by the addition of TWEEN® 20 at a concentration of 0.05% (“0.05% TWEEN® 20”).
- Two droplets were dispensed from each reservoir and kept in position by applying a holding scheme having an intermittency value of 4. After 1 hour of operation, as shown in FIG. 13 B , the 0.05% TWEEN® 20 droplets began to significantly drift from their assigned positions, indicating a degradation in performance and requiring a drop in intermittency to a value of 2 to restore stability and stop drifting.
- drive sequences having an intermittency of at least 4 may enable the manipulation of Tris-buffered droplets for durations of 24 hours or more with no drop in DMF performance.
- lower intermittency is associated with higher efficacy but faster degradation, and vice versa.
- a balance may be struck between these two competing requirements by testing drive sequences of different intermittencies on a given composition until a satisfactory regimen is found. Thereafter, the drive sequences may be made part of holding scheme which is part of the drive profile associated with the composition.
- a search for drive schemes best suited to dispensing aqueous droplets containing TWEEN® 20 as surfactant was conducted on the DMF array of Example 1.
- a 0.1 wt % TWEEN® 20 solution in water was deposited into two reservoirs on the edge of the array, then the drive sequences of Table 1 were each tested for dispensing droplets from the reservoirs into the array.
- the table lists the voltages of pulses applied at each frame in the course of each sequence. As disclosed above, the pulse voltage is the difference in electric potential between the two electrodes associated with a pixel:
- FIG. 14 is a top view of the DMF array after testing of each sequences. Successful dispensing of droplets is framed in green, while failures are framed in red. It can be seen that drive sequence 2 failed to dispense both reservoirs. In contrast, drive sequence 1 successfully dispensed all reservoirs, thereby proving their suitability to TWEEN® 20 aqueous solutions. It is to be understood that the drive sequences are not limited to particular voltage values.
- the high voltage may be +40V, +35V, +30V, +28V, +27V, +25V, +24V, +22V, +20V, +18V, +16V, or +15V
- the corresponding low voltage may be opposite in sign to the corresponding high voltage, i.e., ⁇ 40V, ⁇ 35V, ⁇ 30V, ⁇ 28V, ⁇ 27V, ⁇ 25V, ⁇ 24V, ⁇ 22V, ⁇ 20V, ⁇ 18V, ⁇ 16V, or ⁇ 15V.
- FIG. 15 is a block diagram of an exemplary computing device that can be used to perform one or more steps of the methods provided by exemplary embodiments.
- computing device 1500 may be, but is not limited to the system as described in FIG. 3 A .
- the computing device 1500 includes one or more non-transitory computer-readable media for storing one or more computer-executable instructions or software for implementing exemplary embodiments.
- the non-transitory computer-readable media can include, but are not limited to, one or more types of hardware memory, non-transitory tangible media (for example, one or more magnetic storage disks, one or more optical disks, one or more USB flashdrives), and the like.
- memory 1506 included in the computing device 1500 can store computer-readable and computer-executable instructions or software for implementing exemplary embodiments.
- the computing device 1500 also includes processor 1502 and associated core 1504 , and optionally, one or more additional processor(s) 1502 ′ and associated core(s) 1504 ′ (for example, in the case of computer systems having multiple processors/cores), for executing computer-readable and computer-executable instructions or software stored in the memory 1506 and other programs for controlling system hardware.
- Processor 1502 and processor(s) 1502 ′ can each be a single core processor or multiple core ( 1504 and 1504 ′) processor.
- the computing device 1500 also includes a graphics processing unit (GPU) 1505 . In some embodiments, the computing device 1500 includes multiple GPUs.
- GPU graphics processing unit
- Virtualization can be employed in the computing device 1500 so that infrastructure and resources in the computing device can be shared dynamically.
- a virtual machine 1514 can be provided to handle a process running on multiple processors so that the process appears to be using only one computing resource rather than multiple computing resources. Multiple virtual machines can also be used with one processor.
- Memory 1506 can include a computer system memory or random access memory, such as DRAM, SRAM, EDO RAM, and the like. Memory 1506 can include other types of memory as well, or combinations thereof.
- a user can interact with the computing device 1500 through a visual display device 1518 , such as a touch screen display or computer monitor, which can display one or more user interfaces 1519 .
- the visual display device 1518 can also display other aspects, elements and/or information or data associated with exemplary embodiments.
- the computing device 1500 can include other I/O devices for receiving input from a user, for example, a keyboard or any suitable multi-point touch interface 1508 , a pointing device 1510 (e.g., a pen, stylus, mouse, or trackpad).
- the keyboard 1508 and the pointing device 1510 can be coupled to the visual display device 1518 .
- the computing device 1500 can include other suitable conventional I/O peripherals.
- the computing device 1500 can also include one or more storage devices 1524 , such as a hard-drive, CD-ROM, or other computer readable media, for storing data and computer-readable instructions and/or software, such as one or more components of the system (also referred to as the system 1550 ) shown in FIG. 3 A that implements exemplary embodiments of the notification system as described herein, or portions thereof, which can be executed to generate user interface 1519 on display 1518 .
- Exemplary storage device 1524 can also store one or more databases for storing any suitable information required to implement exemplary embodiments. The databases can be updated by a user or automatically at any suitable time to add, delete or update one or more items in the databases.
- Exemplary storage device 1524 can store one or more databases 1526 for storing provisioned data, and other data/information used to implement exemplary embodiments of the systems and methods described herein.
- the computing device 1500 can include a network interface 1512 configured to interface via one or more network devices 1522 with one or more networks, for example, Local Area Network (LAN), Wide Area Network (WAN) or the Internet through a variety of connections including, but not limited to, standard telephone lines, LAN or WAN links (for example, 802.11, T1, T3, 56 kb, X.25), broadband connections (for example, ISDN, Frame Relay, ATM), wireless connections, controller area network (CAN), or some combination of any or all of the above.
- LAN Local Area Network
- WAN Wide Area Network
- the Internet through a variety of connections including, but not limited to, standard telephone lines, LAN or WAN links (for example, 802.11, T1, T3, 56 kb, X.25), broadband connections (for example, ISDN, Frame Relay, ATM), wireless connections, controller area network (CAN), or some combination of any or all of the above.
- LAN Local Area Network
- WAN Wide Area Network
- CAN controller area network
- the network interface 1512 can include a built-in network adapter, network interface card, PCMCIA network card, card bus network adapter, wireless network adapter, USB network adapter, modem or any other device suitable for interfacing the computing device 1500 to any type of network capable of communication and performing the operations described herein.
- the computing device 1500 can be any computer system, such as a workstation, desktop computer, server, laptop, handheld computer, tablet computer (e.g., the iPad® tablet computer), mobile computing or communication device (e.g., the iPhone® communication device), or other form of computing or telecommunications device that is capable of communication and that has sufficient processor power and memory capacity to perform the operations described herein.
- the computing device 1500 can run any operating system 1516 , such as any of the versions of the Microsoft® Windows® operating systems, the different releases of the Unix and Linux operating systems, any version of the MacOS® for Macintosh computers, any embedded operating system, any real-time operating system, any open source operating system, any proprietary operating system, any operating systems for mobile computing devices, or any other operating system capable of running on the computing device and performing the operations described herein.
- the operating system 1516 can be run in native mode or emulated mode.
- the operating system 1516 can be run on one or more cloud machine instances.
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Dispersion Chemistry (AREA)
- Clinical Laboratory Science (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Analytical Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Physical Or Chemical Processes And Apparatus (AREA)
- Automatic Analysis And Handling Materials Therefor (AREA)
Abstract
Description
TABLE 1 | |
Drive | |
Sequence | Frame Sequence (Pulse Voltages) |
1 | High, Low, 0, High, Low, 0 . . . |
2 | High, Low, High, 0, Low, High, Low, 0 . . . |
Claims (14)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17/497,512 US12179203B2 (en) | 2020-10-08 | 2021-10-08 | Method for reagent-specific driving EWoD arrays in microfluidic systems |
US18/945,393 US20250065333A1 (en) | 2020-10-08 | 2024-11-12 | Method for reagent-specific driving ewod arrays in microfluidic systems |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US202063089066P | 2020-10-08 | 2020-10-08 | |
US17/497,512 US12179203B2 (en) | 2020-10-08 | 2021-10-08 | Method for reagent-specific driving EWoD arrays in microfluidic systems |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US18/945,393 Division US20250065333A1 (en) | 2020-10-08 | 2024-11-12 | Method for reagent-specific driving ewod arrays in microfluidic systems |
Publications (2)
Publication Number | Publication Date |
---|---|
US20220111387A1 US20220111387A1 (en) | 2022-04-14 |
US12179203B2 true US12179203B2 (en) | 2024-12-31 |
Family
ID=78302807
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US17/497,512 Active 2041-10-22 US12179203B2 (en) | 2020-10-08 | 2021-10-08 | Method for reagent-specific driving EWoD arrays in microfluidic systems |
US18/945,393 Pending US20250065333A1 (en) | 2020-10-08 | 2024-11-12 | Method for reagent-specific driving ewod arrays in microfluidic systems |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US18/945,393 Pending US20250065333A1 (en) | 2020-10-08 | 2024-11-12 | Method for reagent-specific driving ewod arrays in microfluidic systems |
Country Status (5)
Country | Link |
---|---|
US (2) | US12179203B2 (en) |
EP (1) | EP4225500A1 (en) |
CN (1) | CN116635152A (en) |
TW (1) | TW202228845A (en) |
WO (1) | WO2022074399A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11977908B2 (en) * | 2021-07-09 | 2024-05-07 | Dish Wireless L.L.C. | Streamlining the execution of software such as radio access network distributed units |
CN119056503A (en) * | 2023-05-31 | 2024-12-03 | 北京京东方传感技术有限公司 | Microfluidic Chip |
US20250060333A1 (en) | 2023-08-16 | 2025-02-20 | E Ink Corporation | Devices, methods, and systems for visualizing electrowetting pathing using electrophoretic materials |
Citations (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6565727B1 (en) | 1999-01-25 | 2003-05-20 | Nanolytics, Inc. | Actuators for microfluidics without moving parts |
US20030205632A1 (en) | 2000-07-25 | 2003-11-06 | Chang-Jin Kim | Electrowetting-driven micropumping |
US6773566B2 (en) | 2000-08-31 | 2004-08-10 | Nanolytics, Inc. | Electrostatic actuators for microfluidics and methods for using same |
US6911132B2 (en) | 2002-09-24 | 2005-06-28 | Duke University | Apparatus for manipulating droplets by electrowetting-based techniques |
US20050179746A1 (en) | 2004-02-16 | 2005-08-18 | Commissariat A L'energie Atomique | Device for controlling the displacement of a drop between two or several solid substrates |
US6977033B2 (en) | 1999-02-12 | 2005-12-20 | Board Of Regents, The University Of Texas System | Method and apparatus for programmable fluidic processing |
US20060039823A1 (en) | 2004-08-17 | 2006-02-23 | Hironobu Yamakawa | Chemical analysis apparatus |
US7052244B2 (en) | 2002-06-18 | 2006-05-30 | Commissariat A L'energie Atomique | Device for displacement of small liquid volumes along a micro-catenary line by electrostatic forces |
US20060164490A1 (en) | 2005-01-25 | 2006-07-27 | Chang-Jin Kim | Method and apparatus for promoting the complete transfer of liquid drops from a nozzle |
US20060194331A1 (en) | 2002-09-24 | 2006-08-31 | Duke University | Apparatuses and methods for manipulating droplets on a printed circuit board |
US7163612B2 (en) | 2001-11-26 | 2007-01-16 | Keck Graduate Institute | Method, apparatus and article for microfluidic control via electrowetting, for chemical, biochemical and biological assays and the like |
US20070023292A1 (en) | 2005-07-26 | 2007-02-01 | The Regents Of The University Of California | Small object moving on printed circuit board |
US20070242111A1 (en) | 2006-04-18 | 2007-10-18 | Pamula Vamsee K | Droplet-based diagnostics |
WO2007120241A2 (en) | 2006-04-18 | 2007-10-25 | Advanced Liquid Logic, Inc. | Droplet-based biochemistry |
US7328979B2 (en) | 2003-11-17 | 2008-02-12 | Koninklijke Philips Electronics N.V. | System for manipulation of a body of fluid |
US20080124252A1 (en) | 2004-07-08 | 2008-05-29 | Commissariat A L'energie Atomique | Droplet Microreactor |
US7547380B2 (en) | 2003-01-13 | 2009-06-16 | North Carolina State University | Droplet transportation devices and methods having a fluid surface |
US20090192044A1 (en) | 2004-07-09 | 2009-07-30 | Commissariat A L'energie Atomique | Electrode addressing method |
US20090283407A1 (en) | 2008-05-15 | 2009-11-19 | Gaurav Jitendra Shah | Method for using magnetic particles in droplet microfluidics |
US20090321262A1 (en) | 2006-07-10 | 2009-12-31 | Sakuichiro Adachi | Liquid transfer device |
US20100096266A1 (en) | 2006-11-02 | 2010-04-22 | The Regents Of The University Of California | Method and apparatus for real-time feedback control of electrical manipulation of droplets on chip |
US20110048951A1 (en) | 2007-06-27 | 2011-03-03 | Digital Biosystems | Digital microfluidics based apparatus for heat-exchanging chemical processes |
US20120007608A1 (en) * | 2010-07-06 | 2012-01-12 | Sharp Kabushiki Kaisha | Array element circuit and active matrix device |
US8173000B1 (en) * | 2011-01-18 | 2012-05-08 | Sharp Kabushiki Kaisha | Active matrix device and method of driving the same |
US20130168250A1 (en) * | 2010-09-16 | 2013-07-04 | Advanced Liquid Logic Inc | Droplet Actuator Systems, Devices and Methods |
US20140151232A1 (en) * | 2012-12-04 | 2014-06-05 | Sharp Kabushiki Kaisha | Active matrix electrowetting-on-dielectric device |
US20170056887A1 (en) * | 2015-08-28 | 2017-03-02 | Sharp Kabushiki Kaisha | Droplet microfluidic device and methods of sensing the results of an assay therein |
US20170073729A1 (en) * | 2015-09-11 | 2017-03-16 | lIIumina, Inc. | Systems and methods for obtaining a droplet having a designated concentration of a substance-of-interest |
US20190317118A1 (en) * | 2018-01-29 | 2019-10-17 | Stratuscent Inc. | Chemical sensing system |
US20200041445A1 (en) * | 2018-07-31 | 2020-02-06 | Taiwan Semiconductor Manufacturing Co., Ltd. | Integrated biological sensing platform |
US20200171500A1 (en) * | 2018-12-03 | 2020-06-04 | Sharp Life Science (Eu) Limited | Am-ewod array element circuitry with integrated sensing and method of sensing droplet merging |
US20220326137A1 (en) * | 2019-06-25 | 2022-10-13 | Sharp Life Science (Eu) Limited | Microfluidic device and a method of manipulating droplets therein |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008098147A1 (en) * | 2007-02-07 | 2008-08-14 | Core Microsolutions, Inc. | Remotely controlled real-time and virtual lab experimentation systems and methods |
US10330920B2 (en) * | 2017-04-04 | 2019-06-25 | Sharp Life Science (Eu) Limited | Droplet actuation method for a microfluidic device |
-
2021
- 2021-10-08 US US17/497,512 patent/US12179203B2/en active Active
- 2021-10-08 CN CN202180080651.4A patent/CN116635152A/en active Pending
- 2021-10-08 WO PCT/GB2021/052611 patent/WO2022074399A1/en active Application Filing
- 2021-10-08 EP EP21794931.2A patent/EP4225500A1/en active Pending
- 2021-10-08 TW TW110137619A patent/TW202228845A/en unknown
-
2024
- 2024-11-12 US US18/945,393 patent/US20250065333A1/en active Pending
Patent Citations (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6565727B1 (en) | 1999-01-25 | 2003-05-20 | Nanolytics, Inc. | Actuators for microfluidics without moving parts |
US6977033B2 (en) | 1999-02-12 | 2005-12-20 | Board Of Regents, The University Of Texas System | Method and apparatus for programmable fluidic processing |
US7641779B2 (en) | 1999-02-12 | 2010-01-05 | Board Of Regents, The University Of Texas System | Method and apparatus for programmable fluidic processing |
US20030205632A1 (en) | 2000-07-25 | 2003-11-06 | Chang-Jin Kim | Electrowetting-driven micropumping |
US6773566B2 (en) | 2000-08-31 | 2004-08-10 | Nanolytics, Inc. | Electrostatic actuators for microfluidics and methods for using same |
US7163612B2 (en) | 2001-11-26 | 2007-01-16 | Keck Graduate Institute | Method, apparatus and article for microfluidic control via electrowetting, for chemical, biochemical and biological assays and the like |
US7052244B2 (en) | 2002-06-18 | 2006-05-30 | Commissariat A L'energie Atomique | Device for displacement of small liquid volumes along a micro-catenary line by electrostatic forces |
US6911132B2 (en) | 2002-09-24 | 2005-06-28 | Duke University | Apparatus for manipulating droplets by electrowetting-based techniques |
US20060054503A1 (en) * | 2002-09-24 | 2006-03-16 | Duke University | Methods for manipulating droplets by electrowetting-based techniques |
US20060194331A1 (en) | 2002-09-24 | 2006-08-31 | Duke University | Apparatuses and methods for manipulating droplets on a printed circuit board |
US7547380B2 (en) | 2003-01-13 | 2009-06-16 | North Carolina State University | Droplet transportation devices and methods having a fluid surface |
US7328979B2 (en) | 2003-11-17 | 2008-02-12 | Koninklijke Philips Electronics N.V. | System for manipulation of a body of fluid |
US20050179746A1 (en) | 2004-02-16 | 2005-08-18 | Commissariat A L'energie Atomique | Device for controlling the displacement of a drop between two or several solid substrates |
US20080124252A1 (en) | 2004-07-08 | 2008-05-29 | Commissariat A L'energie Atomique | Droplet Microreactor |
US20090192044A1 (en) | 2004-07-09 | 2009-07-30 | Commissariat A L'energie Atomique | Electrode addressing method |
US20060039823A1 (en) | 2004-08-17 | 2006-02-23 | Hironobu Yamakawa | Chemical analysis apparatus |
US20060164490A1 (en) | 2005-01-25 | 2006-07-27 | Chang-Jin Kim | Method and apparatus for promoting the complete transfer of liquid drops from a nozzle |
US20070023292A1 (en) | 2005-07-26 | 2007-02-01 | The Regents Of The University Of California | Small object moving on printed circuit board |
WO2007120241A2 (en) | 2006-04-18 | 2007-10-25 | Advanced Liquid Logic, Inc. | Droplet-based biochemistry |
US20070242111A1 (en) | 2006-04-18 | 2007-10-18 | Pamula Vamsee K | Droplet-based diagnostics |
US20090321262A1 (en) | 2006-07-10 | 2009-12-31 | Sakuichiro Adachi | Liquid transfer device |
US20100096266A1 (en) | 2006-11-02 | 2010-04-22 | The Regents Of The University Of California | Method and apparatus for real-time feedback control of electrical manipulation of droplets on chip |
US20110048951A1 (en) | 2007-06-27 | 2011-03-03 | Digital Biosystems | Digital microfluidics based apparatus for heat-exchanging chemical processes |
US20090283407A1 (en) | 2008-05-15 | 2009-11-19 | Gaurav Jitendra Shah | Method for using magnetic particles in droplet microfluidics |
US20120007608A1 (en) * | 2010-07-06 | 2012-01-12 | Sharp Kabushiki Kaisha | Array element circuit and active matrix device |
US20130168250A1 (en) * | 2010-09-16 | 2013-07-04 | Advanced Liquid Logic Inc | Droplet Actuator Systems, Devices and Methods |
US8173000B1 (en) * | 2011-01-18 | 2012-05-08 | Sharp Kabushiki Kaisha | Active matrix device and method of driving the same |
US20140151232A1 (en) * | 2012-12-04 | 2014-06-05 | Sharp Kabushiki Kaisha | Active matrix electrowetting-on-dielectric device |
US20170056887A1 (en) * | 2015-08-28 | 2017-03-02 | Sharp Kabushiki Kaisha | Droplet microfluidic device and methods of sensing the results of an assay therein |
US20170073729A1 (en) * | 2015-09-11 | 2017-03-16 | lIIumina, Inc. | Systems and methods for obtaining a droplet having a designated concentration of a substance-of-interest |
US20190317118A1 (en) * | 2018-01-29 | 2019-10-17 | Stratuscent Inc. | Chemical sensing system |
US20200041445A1 (en) * | 2018-07-31 | 2020-02-06 | Taiwan Semiconductor Manufacturing Co., Ltd. | Integrated biological sensing platform |
US20200171500A1 (en) * | 2018-12-03 | 2020-06-04 | Sharp Life Science (Eu) Limited | Am-ewod array element circuitry with integrated sensing and method of sensing droplet merging |
US20220326137A1 (en) * | 2019-06-25 | 2022-10-13 | Sharp Life Science (Eu) Limited | Microfluidic device and a method of manipulating droplets therein |
Non-Patent Citations (4)
Title |
---|
Choi et al., Digital Microfluidics. Annu Rev Anal Chem (Palo Alto Calif). 2012;5:413-40. |
Dhindsa et al., Virtual electrowetting channels: electronic liquid transport with continuous channel functionality. Lab Chip. 2010;10:832-836. |
International Search Report and Written Opinion for Application No. PCT/GB2021/052611, dated Jan. 10, 2022, 9 pages. |
Ma et al "A floating top-electrode electrowetting-on-dielectric system" RSC Adv.10, 4899-4906 (Year: 2020). * |
Also Published As
Publication number | Publication date |
---|---|
US20220111387A1 (en) | 2022-04-14 |
EP4225500A1 (en) | 2023-08-16 |
TW202228845A (en) | 2022-08-01 |
WO2022074399A1 (en) | 2022-04-14 |
US20250065333A1 (en) | 2025-02-27 |
CN116635152A (en) | 2023-08-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20250065333A1 (en) | Method for reagent-specific driving ewod arrays in microfluidic systems | |
US12027130B2 (en) | Latched transistor driving for high frequency AC driving of EWoD arrays | |
US11410620B2 (en) | Adaptive gate driving for high frequency AC driving of EWoD arrays | |
US20250018395A1 (en) | Dielectric layers for digital microfluidic devices | |
US20210394190A1 (en) | Intermittent driving patterns for extended holding of droplets in a digital microfluidic device | |
US20200384472A1 (en) | Microfluidic devices containing reversibly pinned droplet samples and methods | |
EP4507826A1 (en) | Method for reagent-specific driving ewod arrays in microfluidic systems | |
US20250058316A1 (en) | High voltage driving using top plane switching | |
EP4157532B1 (en) | Spatial and temporal necking for robust multi-size dispensing of liquids on high electrode density electro-wetting arrays | |
WO2022162377A1 (en) | Actuation reduction strategies for droplet motion on high-density electrode arrays for digital microfluidics |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FEPP | Fee payment procedure |
Free format text: ENTITY STATUS SET TO UNDISCOUNTED (ORIGINAL EVENT CODE: BIG.); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
AS | Assignment |
Owner name: NUCLERA NUCLEICS LTD., UNITED KINGDOM Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:PAOLINI, RICHARD J., JR.;SLOMINSKI, LUKE M.;O'MALLEY, TIMOTHY J.;AND OTHERS;SIGNING DATES FROM 20220106 TO 20220221;REEL/FRAME:061326/0210 |
|
AS | Assignment |
Owner name: NUCLERA LTD, UNITED KINGDOM Free format text: CHANGE OF NAME;ASSIGNOR:NUCLERA NUCLEICS LTD.;REEL/FRAME:063436/0255 Effective date: 20230413 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE AFTER FINAL ACTION FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: ADVISORY ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NOTICE OF ALLOWANCE MAILED -- APPLICATION RECEIVED IN OFFICE OF PUBLICATIONS |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: PUBLICATIONS -- ISSUE FEE PAYMENT VERIFIED |
|
STCF | Information on status: patent grant |
Free format text: PATENTED CASE |